An observational study in Cyclic Vomiting Syndrome, sponsored by Central Hospital, Nancy, France. Completed at 1 site in France. Open to participants aged Up to 17 Years. Per ClinicalTrials.gov, last updated 2017-09-28.
Sponsored by Central Hospital, Nancy, France · Observational
The main purpose of this study is the comparison of frequency of vomiting episodes (number of episodes per year) observed during the year after the begin of Q10 coenzyme treatment to frequency observed during the year before the begin of this treatment in children with cyclic vomiting syndrome.
Secondary purposes are the evaluation of life quality of parents and children, of treatment safety and its economic cost compared to other recommended treatments.
Children followed at Children's Hospital of Nancy treated with Q10 coenzyme for cyclic vomiting syndrome
Exclusion Criteria:
Children followed at Children's Hospital of Nancy treated with Q10 coenzyme for cyclic vomiting syndrome
Drug: Q10 Coenzyme
Frequency of vomiting episodes
measured by number of episodes per year
Time frame: from date of inclusion (start of Q10 coenzyme treatment) up to 1 year
Frequency of vomiting episodes
measured by number of episodes per year
Time frame: from 1 year before date of inclusion until date of inclusion (start of Q10 coenzyme treatment)
Intensity of vomiting episodes
reported by the child and/or parents
Time frame: from 1 year before date of inclusion until date of inclusion (start of Q10 coenzyme treatment)
Intensity of vomiting episodes
reported by the child and/or parents
Time frame: from date of inclusion (start of Q10 coenzyme treatment) up to 1 year
Number of child hospitalizations
Time frame: from 1 year before date of inclusion until date of inclusion (start of Q10 coenzyme treatment)
Number of child hospitalizations
Time frame: from date of inclusion (start of Q10 coenzyme treatment) up to 1 year
Cost of Q10 coenzyme treatment and other recommended treatments for cyclic vomiting syndrome
Time frame: baseline
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Sep 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Central Hospital, Nancy, France